Equities researchers at StockNews.com began coverage on shares of Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on the business services provider's stock.
CCRN has been the topic of several other reports. JMP Securities reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a report on Thursday, February 6th. UBS Group decreased their target price on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating for the company in a research note on Tuesday, May 13th. Finally, Barrington Research reiterated a "market perform" rating and issued a $18.61 price objective on shares of Cross Country Healthcare in a research report on Friday, March 14th. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $17.93.
Get Our Latest Research Report on Cross Country Healthcare
Cross Country Healthcare Stock Performance
NASDAQ:CCRN traded down $0.07 during trading hours on Thursday, reaching $13.87. The company's stock had a trading volume of 9,311 shares, compared to its average volume of 585,012. The company has a market capitalization of $454.70 million, a P/E ratio of -277.52, a price-to-earnings-growth ratio of 3.32 and a beta of 0.38. Cross Country Healthcare has a 12 month low of $9.58 and a 12 month high of $18.50. The stock has a 50 day moving average price of $14.36 and a two-hundred day moving average price of $15.54.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. The business's revenue was down 22.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.19 EPS. As a group, analysts predict that Cross Country Healthcare will post 0.53 EPS for the current fiscal year.
Hedge Funds Weigh In On Cross Country Healthcare
Hedge funds have recently made changes to their positions in the company. Quadrant Capital Group LLC purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at approximately $25,000. Plato Investment Management Ltd acquired a new stake in shares of Cross Country Healthcare in the fourth quarter valued at $46,000. Longfellow Investment Management Co. LLC purchased a new position in Cross Country Healthcare in the first quarter valued at $59,000. AlphaQuest LLC raised its position in Cross Country Healthcare by 324.6% in the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock valued at $124,000 after purchasing an additional 6,343 shares in the last quarter. Finally, Mint Tower Capital Management B.V. purchased a new position in shares of Cross Country Healthcare in the 4th quarter valued at about $182,000. Institutional investors and hedge funds own 96.03% of the company's stock.
About Cross Country Healthcare
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.